Correlation Between Cingulate Warrants and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and ZyVersa Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and ZyVersa Therapeutics.
Diversification Opportunities for Cingulate Warrants and ZyVersa Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and ZyVersa is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and ZyVersa Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.65 times more return on investment than ZyVersa Therapeutics. However, Cingulate Warrants is 1.65 times more volatile than ZyVersa Therapeutics. It trades about 0.13 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 4.16 in Cingulate Warrants on September 5, 2024 and sell it today you would earn a total of 0.69 from holding Cingulate Warrants or generate 16.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Cingulate Warrants vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| ZyVersa Therapeutics |
Cingulate Warrants and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and ZyVersa Therapeutics
The main advantage of trading using opposite Cingulate Warrants and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |